Compare XBIT & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | GPRO |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | 85 | N/A |
| Industry | Pharmaceuticals and Biotechnology | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.2M | 154.6M |
| IPO Year | 2015 | 2014 |
| Metric | XBIT | GPRO |
|---|---|---|
| Price | $2.43 | $1.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.8K | ★ 7.6M |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.08 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $651,542,000.00 |
| Revenue This Year | N/A | $23.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.09 | $0.57 |
| 52 Week High | $3.61 | $3.05 |
| Indicator | XBIT | GPRO |
|---|---|---|
| Relative Strength Index (RSI) | 52.08 | 40.59 |
| Support Level | $2.15 | $0.69 |
| Resistance Level | $2.49 | $1.17 |
| Average True Range (ATR) | 0.06 | 0.13 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 56.09 | 9.26 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.